Acne: More than skin deep

Postgraduate Medical Journal

Volumn 82, Issue 970, 2006, Pages 500-506

  Ayer, J ^a,b   Burrows, N ^c  

^a 8 Dorset Mansions ^*  (United Kingdom)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

^c ADDENBROOKE S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADAPALENE; AMINOLEVULINIC ACID; ANTIBIOTIC AGENT; BENZOYL PEROXIDE; CLINDAMYCIN; CYPROTERONE ACETATE; DIANE; DOXYCYCLINE; ERYTHROMYCIN; ETHINYLESTRADIOL; ISOTRETINOIN; ORAL CONTRACEPTIVE AGENT; RETINOIC ACID; TETRACYCLINE; ZINC;

ACNE; ANTIBIOTIC RESISTANCE; BREAST TENDERNESS; CHLOASMA; CLINICAL FEATURE; DRUG EFFICACY; DRUG HYPERSENSITIVITY; DRUG WITHDRAWAL; EYE DISEASE; FLUID RETENTION; GASTROINTESTINAL SYMPTOM; HEADACHE; HORMONAL THERAPY; HUMAN; HYPERTRIGLYCERIDEMIA; MENSTRUATION DISORDER; MYALGIA; NAUSEA; PATIENT COMPLIANCE; PREGNANCY; PRESCRIPTION; REVIEW; SCORING SYSTEM; SKIN DISEASE; ULTRAVIOLET RADIATION; VISUAL DISORDER; VOMITING;

ACNE VULGARIS; ADOLESCENT; ANTI-BACTERIAL AGENTS; DERMATOLOGIC AGENTS; DRUG INTERACTIONS; GRAM-POSITIVE BACTERIAL INFECTIONS; HORMONES; HUMANS; PROPIONIBACTERIUM ACNES; SKIN DISEASES, BACTERIAL;

EID: 33747591927     PISSN: 00325473     EISSN: None     Source Type: Journal    
DOI: 10.1136/pgmj.2006.045377     Document Type: Review

References (78)

1. James WD. Acne. N Engl J Med 2005;352:1463-72.
2. Webster GF. Acne vulgaris. BMJ 2002;325:475-8.
3. Cunliffe WJ, Gould DJ. Prevalence of facial acne in late adolescence and in adults. Br J Dermatol 1979;1:1109-10.
4. Goulden V, Cunliffe WJ. Post adolescent acne. A review of the clinical features. Br J Dermatol 1997;136:66-70.
5. Marks R. Acne; advice on clearing your skin. London: Martin Dunitz, 1986.
6. Kraning KK, Odland GR. Prevalence, morbidity and cost of dermatology diseases. J Invest Dermatol 1979;75(suppl):395-401.
7. Cunliffe W. The acne. London: Dunitz, 1989.
8. Simpson NB. Acne and the mature woman. London: Science Press, 1991.
9. Cunliffe WJ, Gorcha PS, Griffiths WAD, et al. Interfaces in dermatology. Distance learning programme-acne. London: Medical Action Communication, 1997.
10. Rubinow DR, Peck GL, Squillace KM, et al. Reduced anxiety and depression in cystic acne patients after successful treatment with oral isotretinoin. J Am Acad Dermatol 1987;17:25-32.
11. Layton AM, Knaggs H, Taylor J, et al. Isotretinoin for acne vulgaris-10 years later- a safe and successful treatment. Br J Dermatol 1993;129:292-6.
12. Clark SM, Goulden V, Finlay AY, et al. The psychological and social impact of acne. Student using three disability questionnaires. Br J Dermatol 1997;137:41.
13. Jowett S, Ryan T. Skin disease and handicap; an analysis of the impact of skin conditions. Soc Sci Med 1985;20:425-9.
14. Cunliffe W. Acne and unemployment. Br J Dermatol 1986;115:386.
15. Gupta MA, Gupta AK, Schnork NJ, et al. Psychiatric aspects of the treatment of mild to moderate facial acne. Some preliminary observations. Int J Dermatol 1990;29:719-21.
16. Bach M, Bach D. Psychiatric and psychometric issues in acne excoriee. Psychother Psychosom 1993;60:207-10.
17. Koo JY, Smith LL. Psychogenic aspects of acne. Pediatr Dermotol 1991;18:185-8.
18. Papadopoulos L, Bor R, Legg C. Psychological factors in cutaneous diseases. An overview of research. Psychol Health Med 1999;4:107-20.
19. Baldwin HE. The interaction between acne vulgaris and me psyche. Cutis 2002;70:133-9.
20. Kellet SC, Gawkrodger DJ. The psychosocial and emotional impact of acne and the effect of treatment with Isotretinoin. Br J Dermatol 1999;140:272-82.
21. Cotteril JA, Cunliffe WJ. Suicide in dermatology patients. Br J Dermotol 1997;137:246-50.
22. Mallon EM, Newton JN, Klassen A, et al. The quality of life in acne: a comparison with general medical conditions using generic questionnaires. Br J Dermatol 1999;140:672-6.
23. Bataille V, Sneider H, MacGregor AJ, et al. The influence of genetic and environmental factors in the pathogenesis of acne: a twin study of acne in women. J Invest Dermatol 2002;119:1317-22.
24. Chiu A, Chon SY, Kimball AB. The response of skin to stress. Arch Dermatol 2003;139:897-900.
25. Cunliffe WJ, Gollnick HPM. Acne diagnosis and management. London: Martin Dunitz, 2001.
26. Shalita AR. Acne revisited. Arch Dermatol 1994;130:363-4.
27. Schafer T, Nienhaus A, Vieluf D, et al. Epidemiology of acne in general population. The risk of smoking. Br J Dermatol 2001;145:100-4.
28. Fries JH. Chocolate; A reiew of published reports of allergic and other deleterious effects. Real or presumed. Ann Allergy Asthma Immunol 1978;41:195-207.
29. Fulton JE, Plewing C, Klingman AM. Effect of chocolate on acne vulgaris. VAMA 1969;210:2071-4.
30. Chu TC. Acne and other facial eruptions. Medicine 1997;25:30-3.
31. Gollnick H, Cunliffe WJ, Berson D, et al. Management of acne: a report from a global alliance to improve outcomes in Acne. J Am Acad Dermatol 2003;49(suppl 1):S1-37.
32. Thiboutot DM. An overview of acne and its treatments. Cutis 1996;57:8-12.
33. Feldman S, Careccia RE, Berham KL, et al. Diagnosis and treatment of acne. Am Fam Physician 2004;69:2123.
34. Norris JE, Cunliffe WJ. A histological and immunocytochemical study of early acne lesions. Br J Dermatol 1988;118:651-9.
35. Whipp MJ, C. I. H, Dundas S. Fatal squamous cell carcinoma associated with acne conglobata in a father and daughter. Br J Dermatol 1987;117:389-92.
36. Veradi DP, Saqueton AC. Perifollicular elastocytosis. Br J Dermatol 1970;83:143-50.
37. O'Brien SC, Lewis JB, Cunliffe WJ. The Leeds revised acne grading system. J Dermatolog Treat 1998;9:215-20.
38. Layton A. Psychological assessment of skin disease. Interfaces Dermatol 1994;1:9-11.
39. Motley R, Finlay AY. Acne disability index. Practical use of disability index in the routine management of acne. Exp Dermatol 1992;17:1-3.
40. Kingman A, Mills O. Arch Dermatol 1972;106:843-50.
41. Cunliffe WJ, Holland KT. The effect of benzoyl peroxide in acne. Acta Derm Venereol 1980;61:267-9.
42. Haider A, Shaw JC. Treatment of acne vulgaris. JAMA 2004;292:726-35.
43. Berson DS, Shalita AR. The treatment of acne; the role of combination therapies. J Am Acad Dermatol 1995;32:532-41.
44. Leyden JJ, McGinley K, Mills OK, et al. Topical antibiotics and topical antimicrobial agents in acne therapy. Acfa Derm Venereal 1980;89:75-81.
45. Brown SK, Shalita AE. Acne vulgaris. Lancet 1998;3511871-8.
46. Vega B, Jomard A, Michael S. Regulation of toll-like receptor 2 expression by adapaline. J Eur Acad Dermatol Venereal 2002;16:123-4.
47. Gollnick H, Schram M. Topical drug treatment for acne. Dermatology 1998;196:119-25.
48. Thiboutot D. New treatment and therapeutic strategies for Acne. Arch Fam Med 2000;9:179-87.
49. Meynadier J, Alirezai M. Systemic anitbiotics for acne. Dermatology 1988;196:135-9.
50. Golt Z, Ujartanssons S. Oral tetracycline treatment on bacterial flora in acne vulgaris. Arch Dermatol 1966;93:92-100.
51. Layton A. Systemic therapy of acne vulgaris. Br J Hosp Med 2004;65:80-5.
52. Cunliffe WJ, Meynadier J, Alirezai M, et al. Is combined oral and topical therapy better than oral therapy alone in patients with moderate to moderately severe acne vulgaris? A comparison of the efficacy and safety of lymecycline plus adapalene gel 0.1%, versus lymecycline plus gel vehicle. J Am Acad Dermatol 2003;49(suppl 3):S218-26.
53. Eady EA, Cove JH, Holland KT, et al. Erythromycin resistant P bacteria in antibiotics treated acne patients; association with therapeutic failure. Br J Dermatol 1989;121:51-7.
54. Cooper AL. Systematic review of P. acne resistance to systemic antibiotics. Med J Aust 1998;169:259-61.
55. Coates P, Vyakmams S, Eady EA, et al. Prevalence of antibiotic resistant P bacteria on the skin of acne patients: a ten year surveilance data and snapshot distribution and study. Br J Dermatol 2002;146:840-8.
56. Simpson N. Antibiotics in acne; time for rethink. Br J Dermatol 2001;144:225-8.
57. Ross J, Snelling AM, Eady EA, et al. Phenotypic and genotypic characterization of antibiotic resistant P. bacteria isolated from acne patients attending dermatology clinics in Europe, the USA, Japan and Australia. Br J Dermatol 2001;144:339-45.
58. Tan JKL. Psychosocial impact of acne vulgaris: evaluating the evidence. Skin Therapy Lett. 2004;9: 1-3, 91.
59. Cunliffe W. Propionibacterium acnes resistance and its clinical relevance. J Dermotolog Treat 1995;6(suppl 1):S3-4.
60. Archer J, Archer D. Oral contraceptive efficacy and antibiotic interaction: a myth debunked. J Am Acad Dermatol 2002;46:917-23.
61. Peek GL, Olsen TG, Burkaus D, et al. versus placebo in the treatment of cystic acne. A randomised double blind study. J Am Acad Dermatol 1982;6:735-45.
62. King K, Jones DH, Daltry DC, et al. A double blind study of the effects of 13-cis-retinoic acid on acne sebum excretion rate and microbial population. Br J Dermatol 1982;107:583-90.
63. Leyden J, James WD. Staphylococcal infection as a complication of isotretinoin therapy. Arch Dermotol 1987;123:606-8.
64. Simpson N. Effect of isotretinoin on the quality of life of patients with acne. Phormacoeconomics 1994;6:108-13.
65. Mergel W. How safe is oral isotretinoin? Dermatology 1997;195(suppl 1):22-8.
66. Wysoski DK, Pitts M, Beitz J. An analysis of reports of depression and suicide in patients treated with Isotretinoin. J Am Acad Dermatol 2001;45:515-19.
67. Hazen P, Carney J, Walker K, et al. Depression- a suicide effect of 13-cisretinoic acid therapy. J Am Acad Dermatol 1983;8:278-9.
68. Hull PR, D'Arcy C. Isotretinoin use and subsequent depression and suicide presenting the evidence. Am J Clin Dermatol 2003;4:493-505.
69. Jacobs DG, Deutsch NL, Brewer M. Suicide, depression and isotretinoin. Is there a causal link? J Am Acad Dermatol 2001;45:S168-75.
70. Ng CH, Schweitzer I. The association between depression and isotretinoin use in acne. Aust N Z J Psychiatry 2003;37:78-84.
71. Pepall LM, Cosgrove MP, Cunliffe WJ. Ablation of whiteheads by cautery under topical anaesthesia, Br J Dermatol 1991;125:256-9.
72. Oringer JS, Kong S, Hamilton T, et al. Treatment of acne vulgaris witfi a pulsed dye laser. JAMA 2004;29:2834-9.
73. Tsai RY, Wont CN, Chan HL. Aluminium oxide crystal microderm abrasion. A new technique for treating acne scarring. Dermatol Surg 1995;21:539-42.
74. Coleman WP. Dermabrasion and hypertrophic scars. Int J Dermatol 1991;30:629-31.
75. Ernst K, Hundeiker M. Results of cryosurgery in 394 patients with hypertrophic scars and keloids. Hautarzt 1995;46:462-6.
76. Green J, Sinclair RD. Perceptions of acne vulgaris in final year medical student. Written examination answers. Australas J Dermatol 2001;42:98.
77. Bradley C. Compliance with drug therapy. Presenter 1999;39:44-50.
78. Marshall M. From compliance to concordance; achieving shared goals in medicine taking. London: RPS, 1997.